GRAIL Inc

GRALNASDAQ · USD
121.44USD+2.31 (+1.94%)
2310

GRAIL Inc (GRAL) Option Chain

GRAIL Inc trades at $121.44, up 1.94%, with an IV Rank of 62.70%. This is average versus the past year, and the company carries a market cap of $5,321M in the Diagnostics & Research industry. On the Nov 20, 2026 chain, the at the money $120.00 strike shows calls at $7.40 / $10.70 and puts at $7.60 / $10.90, both carrying about $8.43 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $160.00 calls, at 85 contracts, and the $120.00 puts, at 69, as of Nov 5, 2026.

Read more

Tracking the GRAL option chain helps you see every strike and expiry on GRAIL Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of GRAL options activity at a glance. Use our scanner to monitor the GRAL option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For GRAL stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where GRAL options are being actively traded, and where they are not.

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
36.812433.2111.4413.1016.20110.00-7.663.205.600.004.40117063.19
45.973925.366.4410.4013.20115.00-3.475.208.000.006.6072654.03
54.955797.611.447.4010.70120.00+0.737.6010.900.009.256930545.05
63.3374157.300.005.808.80125.00+4.9310.6013.803.568.642142136.67
70.8499195.850.004.507.20130.00+9.1214.1017.008.566.99136829.16

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryDiagnostics & Research
  • SectorHealthcare
  • IV Rank62.70% Moderate
  • Market cap (M$)5,321
  • 52 weeks high-28.44%
  • 52 weeks low187.06%
  • Analyst recommendationBuy
    2.33
  • Target price$133.22
    9.16% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E—
  • Future P/E—
  • EPS (ttm)-9.50
  • EPS growth next 5 years4.49%

As of Nov 5, 2026